Antimicrobial Peptide Discovery on AMP Discovery (epsilon=0.2)
63,343.4Unique predicted-resistant peptidesB3-TR
Evaluation Results
| Method | Links | |
|---|---|---|
| B3-TRModel=Boosted GFlowNet, Number of models=3, Objective variant=Target-Residual (TR), Alpha=0.02025.11 | 63,343.4 | |
| B2-TRModel=Boosted GFlowNet, Number of models=2, Objective variant=Target-Residual (TR), Alpha=0.02025.11 | 59,536.6 | |
| B3-FAModel=Boosted GFlowNet, Number of models=3, Objective variant=Flow-Additive (FA), Alpha=1.02025.11 | 24,663.2 | |
| SGModel=Single GFlowNet, Number of models=12025.11 | 14,872 | |
| B2-FAModel=Boosted GFlowNet, Number of models=2, Objective variant=Flow-Additive (FA), Alpha=1.02025.11 | 6,066.6 |